REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Innovative Treatment for Hypertension Successfully Completed at Sheba Medical Center

Hypertension Treatment
The latest treatment for hypertension revolves around a new procedure, which is minimally invasive and performed via catheterization, helps hypertensive patients who do not respond to medication.

Hypertension is most commonly treated pharmacologically, but in many cases this might not be enough. An older surgical option, sympathectomy, is rather invasive, involves a comparatively long recovery period, and has many side effects. However, a new type of treatment, renal denervation, is now being made available in select medical institutions, including Sheba Medical Center.

The kidneys are part of the body’s blood pressure regulation mechanism, and overactive nerves surrounding the renal arteries is thought to be one of the major causes of high blood pressure. Nevertheless, these nerves can be ablated to help the kidneys better manage blood pressure.

Renal denervation (RDN) is a minimally invasive procedure that involves intravenous insertion of a multi-electrode renal denervation catheter that ablates the renal artery nerves with heat generated from a radiofrequency current. The procedure does not require anesthetization since radiofrequency currents do not directly stimulate nerves. Recent studies indicate that RDN may help achieve a sustained reduction in blood pressure, independent of patient medication adherence.

Hypertension Treatment

For the first time at Sheba Medical Center, a 60-year-old patient suffering from hypertension was successfully treated with this innovative procedure. “The procedure is designed to help patients who do not respond to medication or suffer from side effects as a result of medication use. This marks a major breakthrough for patients that, up to now, were regarded as ‘ticking time bombs,’” says Prof. Jonathan Sharabi, Deputy Director of the Department of Internal Medicine and Director of the Hypertension Unit at Sheba Medical Center, who added: “The use of advanced technologies plays an integral part in the process of shaping the medicine of the future, and also enables us to provide hope for many patients.”

Related

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More